The ways in which HCPs prefer to engage with pharma has been changing for quite some time, and the digital transformation brought by COVID has dramatically accelerated that.
A large number of US consumers are wary of content from social media, presenting opportunities for pharma to become trusted resources for health information, says Richard Meyer.